# Clinical Trial of Efficacy and Safety of Rengalin in the Treatment of Cough in Patients With Chronic Obstructive Pulmonary Disease

> **NCT03159091** · PHASE4 · COMPLETED · sponsor: **Materia Medica Holding** · enrollment: 238 (actual)

## Conditions studied

- Chronic Obstructive Pulmonary Disease

## Interventions

- **DRUG:** Rengalin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03159091
- **Lead sponsor:** Materia Medica Holding
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-06-16
- **Primary completion:** 2019-04-25
- **Final completion:** 2019-04-25
- **Target enrollment:** 238 (ACTUAL)
- **Last updated:** 2020-12-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03159091

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03159091, "Clinical Trial of Efficacy and Safety of Rengalin in the Treatment of Cough in Patients With Chronic Obstructive Pulmonary Disease". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT03159091. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*